OptimizeRx Corp — Director's Dealing 2021

Jul 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-07-20

Reporting Person: Silvestro Stephen L (CHIEF COMMERCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-20	Common Stock	M	13242	$7.51	Acquired	13242	Direct
2021-07-20	Common Stock pursuant to 10B5-1 plan	S	13242	$50.34	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-20	Stock Option	$7.51	M	13242	Disposed	2025-03-11	Common Stock (13242)	Direct

Footnotes

F1: These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.